Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated:  10/11/2015
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated: 10/11/2015
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated:  10/11/2015
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated: 10/11/2015
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated:  10/11/2015
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated: 10/11/2015
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated:  10/11/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma
Status: Enrolling
Updated: 10/11/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  10/12/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 10/12/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  10/12/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 10/12/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  10/12/2015
James Graham Brown Cancer Center
mi
from
Louisville, KY
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 10/12/2015
James Graham Brown Cancer Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  10/12/2015
Washington University
mi
from
Saint Louis, MO
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 10/12/2015
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  10/12/2015
Local Institution
mi
from
Buenos Aires,
Phase I/II Combination With Irinotecan- Erbitux
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 10/12/2015
Local Institution
mi
from
Buenos Aires,
Click here to add this to my saved trials
Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
A Phase II Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
Status: Enrolling
Updated:  10/17/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
A Phase II Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
Status: Enrolling
Updated: 10/17/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical and Translational Study of STA-9090
A Phase II Clinical and Translational Study of STA-9090 in Patients With Refractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  10/19/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Clinical and Translational Study of STA-9090
A Phase II Clinical and Translational Study of STA-9090 in Patients With Refractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 10/19/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis
Status: Enrolling
Updated:  10/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis
Status: Enrolling
Updated: 10/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated:  10/22/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated: 10/22/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Visceral Lymphatic Mapping Project: A Pilot Study
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Visceral Lymphatic Mapping Project: A Pilot Study
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Improving Fecal Occult Blood Test Completion Rates Among Veterans
Improving Fecal Occult Blood Test Completion Rates Among Veterans
Status: Enrolling
Updated:  10/23/2015
Philadelphia Veterans Affairs Medical Center
mi
from
Philadelphia, PA
Improving Fecal Occult Blood Test Completion Rates Among Veterans
Improving Fecal Occult Blood Test Completion Rates Among Veterans
Status: Enrolling
Updated: 10/23/2015
Philadelphia Veterans Affairs Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Duarte, CA
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Duarte, CA
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Tampa, FL
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Tampa, FL
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Baltimore, MD
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
St. Louis, MO
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
St. Louis, MO
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
New Brunswick, NJ
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Bronx, NY
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Bronx, NY
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Cincinnati, OH
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Cleveland, OH
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Hershey, PA
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Hershey, PA
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Philadelphia, PA
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Nashville, TN
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Nashville, TN
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
San Antonio, TX
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated:  10/26/2015
Local Institution
mi
from
Montreal,
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Status: Enrolling
Updated: 10/26/2015
Local Institution
mi
from
Montreal,
Click here to add this to my saved trials
Optimizing Navigation to Successful Colorectal Cancer Screening
Optimizing Navigation to Successful Colorectal Cancer Screening
Status: Enrolling
Updated:  10/26/2015
Rush University Medical Center
mi
from
Chicago, IL
Optimizing Navigation to Successful Colorectal Cancer Screening
Optimizing Navigation to Successful Colorectal Cancer Screening
Status: Enrolling
Updated: 10/26/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Status: Enrolling
Updated:  10/28/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Status: Enrolling
Updated: 10/28/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Motivational Interviewing for Colonoscopy
Motivational Interviewing for Colonoscopy: A Feasibility and Pilot Study
Status: Enrolling
Updated:  11/3/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Motivational Interviewing for Colonoscopy
Motivational Interviewing for Colonoscopy: A Feasibility and Pilot Study
Status: Enrolling
Updated: 11/3/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated:  11/3/2015
Aurora St. Luke's Hospital
mi
from
Milwaukee, WI
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated: 11/3/2015
Aurora St. Luke's Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated:  11/3/2015
Aurora West Allis
mi
from
West Allis, WI
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated: 11/3/2015
Aurora West Allis
mi
from
West Allis, WI
Click here to add this to my saved trials
A Study of Mitomycin C, Irinotecan, and Cetuximab
A Phase II Study of Mitomycin C, Irinotecan and Cetuximab in Patients With Previously Treated, Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/4/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
A Study of Mitomycin C, Irinotecan, and Cetuximab
A Phase II Study of Mitomycin C, Irinotecan and Cetuximab in Patients With Previously Treated, Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/4/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Arizona Clinical Research Center
mi
from
Tucson, AZ
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Arizona Clinical Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Florida Cancer Specialists
mi
from
Fort Myers, FL
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Clearview Cancer Institute
mi
from
Huntsville, AL
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Clearview Cancer Institute
mi
from
Huntsville, AL
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Lombardi Comprehensive Cancer Center, Georgetown University Hospital
mi
from
Washington,
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Lombardi Comprehensive Cancer Center, Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
University of Florida COllege of Medicine/Shands Cancer Center
mi
from
Gainesville, FL
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
University of Florida COllege of Medicine/Shands Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
NYU Clinical Trials Office, New York University Cancer Institute
mi
from
New York, NY
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
NYU Clinical Trials Office, New York University Cancer Institute
mi
from
New York, NY
Click here to add this to my saved trials
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  11/5/2015
Sarah Cannon Research Institute
mi
from
Nashville, TN
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/5/2015
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated:  11/7/2015
Oncology Associates D.B.A. Hematology Oncology Physicians & Extenders
mi
from
Tucson, AZ
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Oncology Associates D.B.A. Hematology Oncology Physicians & Extenders
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated:  11/7/2015
Melbourne Internal Medicine Associates
mi
from
Melbourne, FL
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Melbourne Internal Medicine Associates
mi
from
Melbourne, FL
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated:  11/7/2015
Advanced Medical Specialties
mi
from
Miami, FL
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Advanced Medical Specialties
mi
from
Miami, FL
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated:  11/7/2015
Cancer Centers of Florida
mi
from
Ocoee, FL
Pre-op Rectal ChemoRad +/- Cetuximab
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Cancer Centers of Florida
mi
from
Ocoee, FL
Click here to add this to my saved trials